How to Buy Moderna Stock
Moderna Inc
Moderna, Inc. , a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally.
Moderna stock last closed at $152.10, down 1.57% from the previous day, and has decreased 13.27% in one year. It has overperformed other stocks in the Biotechnology industry by 0.11 percentage points. Moderna stock is currently +32.23% from its 52-week low of $115.03, and -29.99% from its 52-week high of $217.25.
There are currently 386.34M shares of MRNA outstanding. The market value of MRNA is $58.76B. In the past 24 hours, 2.99M MRNA shares were traded.
How to Buy Moderna Stock
Not sure how to invest in Moderna stock? Here's how.
- Decide where to buy Moderna stock: You need to decide on a stock brokerage, but don't worry - we've tested dozens of stock brokerages and apps to help you determine where to buy Moderna stock.
- Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Fund your investment account: Select your payment method and add your details.
- Research Moderna stock: The Moderna ticker symbol is MRNA. Is Moderna stock a good investment? Should you buy shares of MRNA? How do MRNA's underlying business fundamentals look? Do top analysts think Moderna is a good buy? Why has MRNA's stock price moved recently? (Hint: Our stock market research tools can help you evaluate if MRNA is a good stock to buy).
- Make your MRNA purchase: Decide if you will purchase MRNA shares at the current market price or use a limit order to purchase MRNA shares at a particular price.
- Track your MRNA investment: Create a watchlist to watch your new investment in Moderna shares.
Step 1: Decide where to buy Moderna stock
You will need an online brokerage account to access the NASDAQ market and buy MRNA stock.
Our preferred brokerage: eToro
Based on our analysis, eToro is the best stock brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to world financial markets: From Tech to Utilities, New York to Shanghai — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro boasts a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by creating an account with eToro now.
Open eToro AccountStep 2: Open a brokerage account
Now that you've chosen the best brokerage, you'll need to fill out some personal information so you are able to buy MRNA today.
How to Create a New Investment Account on eToro
- Click here to get started.
- Enter your personal data to open a new trading account.
- Submit your application by pressing the "Create Account" button.
Step 3: Fund your investment account
Now that you've filled out your info on the best stock trading app, you need to deposit funds:
Check out the tutorial below to see the process of transferring funds into your new investment account.
Step 4: Research Moderna stock
After you have figured out the best place to buy Moderna stock, it's crucial to research their stock prior to investing, so you can comprehend the risk as well as the opportunity.
Moderna quick stats
MRNA Fundamentals
WallStreetZen was created to help part-time investors do more in-depth fundamental analysis in less time.
You can see all of the due diligence checks on MRNA's stock page.
How is MRNA stock valued?
Analysts use many financial metrics, analyses, models, and charts to gauge MRNA's fair value.
Using relative valuations ratios:
- MRNA may be undervalued based on its P/E ratio of 7.15x, relative to Biotechnology industry P/E ratio of 16.62x
- MRNA may be undervalued based on its P/B ratio of 3.07x, relative to Biotechnology industry P/B ratio of 4.85x
You can do more valuation analysis on MRNA's stock here.
A quick look at MRNA Financials
Passed Financial Due Diligence Checks:
- There are more short-term assets than long-term liabilities on the MRNA balance sheet.
- MRNA's operating cash flow of $4.98B allows it to safely service it's debt of $1.00B.
- Total MRNA debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than short-term liabilities on the MRNA balance sheet.
- MRNA has a low debt to equity ratio of 0.35.
- MRNA earnings of $9.58B is not enough to cover its interest payments.
Failed Financial Due Diligence Checks:
- MRNA profit margin has gone down from 66.1% to 43.4% in the past year.
Is it a good time to buy MRNA stock, according to Wall Street analysts?
Out of 11 sell side analysts who research MRNA, the consensus analyst rating on Moderna is a Buy
It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they financial advice.
Most Recent MRNA Analyst Upgrades/Downgrades
Tyler Van Buren, a bottom 6% analyst from TD Cowen upgrades MRNA to a buy rating and raises their MRNA price target from $150.00 to $180.00, on Mar 13, 2023.
Luca Issi, a bottom 2% analyst from RBC Capital initiates coverage on MRNA with a buy rating and announces their MRNA price target of $200.00, on Mar 2, 2023.
Emmanuel Papadakis, a top 28% analyst from Deutsche Bank maintains MRNA with a strong buy rating and lowers their MRNA price target from $225.00 to $200.00, on Feb 28, 2023.
Mani Foroohar, a bottom 1% analyst from SVB Leerink downgrades MRNA to a sell rating and lowers their MRNA price target from $111.00 to $93.00, on Feb 24, 2023.
Jessica Fye, a top 11% analyst from JP Morgan maintains MRNA with a hold rating and raises their MRNA price target from $132.00 to $138.00, on Feb 8, 2023.
You can dig deeper into what analysts are forecasting on the Moderna stock forecast page.
MRNA Momentum
Is MRNA Making Money?
Last year, MRNA earnings were $8.36B. Over the past 1 years, MRNA's earnings have grown by -29.86% per year. This was slower than the Biotechnology industry average of 9.38%.
Last year, MRNA revenue was $19.26B. During the past five year, MRNA's revenue has grown by 147.88% per year. This was faster than the Biotechnology industry average of 50.9%.
Learn more about MRNA's earnings and revenue performance here.
Latest Insiders Trades at MRNA
Over the last year, insiders at MRNA have sold more shares than they have bought.
Stephane Bancel, Chief Executive Officer of MRNA, was the latest MRNA insider to sell. They sold $559,333.32 worth of MRNA shares on Mar 16, 2023.
Dig into more about who owns MRNA shares here.
Does MRNA stock generate passive income?
No, Moderna doesn't provide an income stream by paying out dividends.
MRNA Social Trading Data
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Make your MRNA purchase
You have two primary options:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are generally fine. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a given price, place a limit order.
Click the Open button and eToro will execute your order.
If you need more help investing in stocks on eToro, click the how to video below:
Step 6: Track your MRNA investment
Now that you own some MRNA stock, you'll want to keep up with your investment.
Create a watchlist to monitor your MRNA stock.
MRNA Feed
How to Buy Stock in Moderna
To summarize, here are the 6 steps to buy Moderna stock:
- Decide where to buy Moderna stock
- Open a brokerage account
- Fund your investment account
- Research Moderna stock
- Make your MRNA purchase
- Track your MRNA investment
If you need a brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get the latest news on your new investment in Moderna, add MRNA to your watchlist below.
Trending Stock Buying Guides
FAQ
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.